How Ghrelin and CCK Work Together to Control Your Hunger and Fullness Signals
A review explaining how the hunger hormone ghrelin and the satiety hormone cholecystokinin interact with GLP-1, amylin, and other gut peptides to form the body's appetite control network.
Quick Facts
What This Study Found
This review maps how gut peptides from the stomach and upper small intestine work together to control hunger and fullness. Ghrelin, produced in stomach X/A-like cells, is the only known peripheral hormone that stimulates appetite. Cholecystokinin (CCK) from the duodenum is its main counterpart, suppressing appetite. These two peptides interact directly, creating a regulatory network at the first point of nutrient contact.
Several other peptides — including leptin, urocortin 2, amylin, and GLP-1 — amplify CCK's satiety signal through synergistic interactions. The review also highlights newer peptides discovered in the same stomach cells as ghrelin: obestatin (from the pro-ghrelin gene) and nesfatin-1 (from the nucleobindin2 gene), both under investigation for appetite regulation.
Key Numbers
How They Did This
Narrative review of the scientific literature on gastric and upper small intestinal peptide hormones involved in appetite regulation, their central nervous system targets (brainstem, hypothalamus), and their interactions.
Why This Research Matters
Understanding the peptide network that controls hunger and satiety is the scientific foundation behind modern weight loss drugs like GLP-1 agonists (semaglutide, tirzepatide). This review explains why appetite regulation isn't controlled by a single hormone but by a complex web of interacting gut peptides — and why drugs targeting multiple pathways simultaneously may be more effective than single-target approaches.
The Bigger Picture
The multi-peptide appetite control system described in this review directly explains why modern obesity drugs are moving toward multi-receptor targeting. Tirzepatide hits GLP-1 and GIP receptors; retatrutide hits three. Understanding that satiety is 'redundantly controlled' by many peptides working together explains why single-target drugs have limited effectiveness and why combination approaches are the future of metabolic medicine.
What This Study Doesn't Tell Us
Published in 2011, so it predates many recent developments in GLP-1 agonist therapeutics and newer discoveries in gut-brain peptide signaling. As a narrative review, it synthesizes existing evidence rather than generating new data.
Questions This Raises
- ?Could drugs that simultaneously target ghrelin suppression and CCK enhancement be more effective for appetite control than GLP-1 agonists alone?
- ?What role do the newer peptides obestatin and nesfatin-1 play in human appetite regulation beyond animal models?
- ?How do individual variations in gut peptide production explain why some people respond better to GLP-1 drugs than others?
Trust & Context
- Key Stat:
- Ghrelin: the only peripheral hunger hormone Of all the peptides produced in the gut, ghrelin is the sole hormone that travels to the brain to stimulate appetite — while satiety is controlled by many redundant signals
- Evidence Grade:
- This is a review article synthesizing established research on gut peptide physiology. The individual findings it discusses come from a wide range of study types, from basic science to clinical research, but the review itself does not generate new data.
- Study Age:
- Published in 2011, this review predates the GLP-1 agonist therapeutic revolution but provides foundational understanding of the peptide systems these drugs target. The core physiology described remains accurate.
- Original Title:
- Interaction between gastric and upper small intestinal hormones in the regulation of hunger and satiety: ghrelin and cholecystokinin take the central stage.
- Published In:
- Current protein & peptide science, 12(4), 293-304 (2011)
- Authors:
- Stengel, Andreas(4), Taché, Yvette(3)
- Database ID:
- RPEP-01867
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Why is ghrelin called 'the hunger hormone'?
Ghrelin is the only hormone produced in the gut that travels to the brain and stimulates appetite. It's made in specialized stomach cells and rises before meals, telling your brain it's time to eat. After you eat, ghrelin drops and satiety hormones like CCK and GLP-1 take over. This unique role as the body's only peripheral appetite stimulator is why it earned the nickname.
How does this relate to drugs like Ozempic and Mounjaro?
These drugs mimic GLP-1, one of the satiety peptides described in this review. GLP-1 normally amplifies fullness signals from CCK after eating. By providing a constant, enhanced GLP-1 signal, drugs like semaglutide (Ozempic) essentially keep the 'I'm full' message active for much longer than natural GLP-1 does, which is why they reduce appetite so effectively.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-01867APA
Stengel, Andreas; Taché, Yvette. (2011). Interaction between gastric and upper small intestinal hormones in the regulation of hunger and satiety: ghrelin and cholecystokinin take the central stage.. Current protein & peptide science, 12(4), 293-304.
MLA
Stengel, Andreas, et al. "Interaction between gastric and upper small intestinal hormones in the regulation of hunger and satiety: ghrelin and cholecystokinin take the central stage.." Current protein & peptide science, 2011.
RethinkPeptides
RethinkPeptides Research Database. "Interaction between gastric and upper small intestinal hormo..." RPEP-01867. Retrieved from https://rethinkpeptides.com/research/stengel-2011-interaction-between-gastric-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.